DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR NESINA

« Back to Dashboard

Clinical Trials for Nesina

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00856284	Efficacy and Safety of Alogliptin Plus Metformin Compared to Glipizide Plus Metformin in Patients With Type 2 Diabetes Mellitus	Completed	Takeda	Phase 3	The purpose of this study is to determine the safety and effectiveness of adding alogliptin, once daily (QD), compared to glipizide with metformin in diabetic patients.
NCT01664624	Roflumilast Plus Alogliptin Proof-of-Mechanism Study in Type2 Diabetes	Completed	Takeda	Phase 1	The purpose of this study is to assess the effect of roflumilast plus alogliptin on glucagon-like peptide-1 (GLP-1) and glucose levels in patients with type 2 diabetes.
NCT01945216	Alogliptin Tablets Special Drug Use Surveillance "Type 2 Diabetes Mellitus: Monotherapy/Combination Therapy With α-GI"	Completed	Takeda	N/A	The purpose of this study is to determine the safety and efficacy of long-term treatment with alogliptin (Nesina) in patients with type 2 diabetes mellitus who responded inadequately to diet therapy and exercise therapy alone, or a combination of diet therapy, exercise therapy, and α-glucosidase inhibitor. In addition, examining the safety and efficacy of alogliptin in patients with renal impairment, information on the appropriate dosage of alogliptin according to the severity of impaired renal function should be collected.
NCT01945242	Alogliptin Tablets Special Drug Use Surveillance "Type 2 Diabetes Mellitus: Combination Therapy With Thiazolidinediones"	Completed	Takeda	N/A	The purpose of this study is to determine the safety and efficacy of long-term combination therapy with alogliptin (Nesina) and thiazolidinediones in patients with type 2 diabetes mellitus who failed to respond adequately to treatment with thiazolidinediones in addition to diet therapy and exercise therapy.

Clinical Trial Conditions for Nesina

Condition Name

Condition Name for Nesina
Intervention	Trials
Diabetes Mellitus, Type 2	4
Type 2 Diabetes Mellitus	3
Surveillance	3
Type 2 Diabetes Melitus	1

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Nesina
Intervention	Trials
Diabetes Mellitus, Type 2	13
Diabetes Mellitus	13

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Nesina

Trials by Country

Trials by Country for Nesina
Location	Trials
United States	38
Hungary	8
Israel	7
India	7
Japan	5

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Nesina
Location	Trials
California	3
Florida	2
Georgia	2
Nevada	1
Oklahoma	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Nesina

Clinical Trial Phase

Clinical Trial Phase for Nesina
Clinical Trial Phase	Trials
Phase 4	3
Phase 3	2
Phase 1	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Nesina
Clinical Trial Phase	Trials
Completed	7
Recruiting	3
Not yet recruiting	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Nesina

Sponsor Name

Sponsor Name for Nesina
Sponsor	Trials
Takeda	12
Kun-Ho Yoon	2
Fourth People's Hospital of Shenyang	1

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Nesina
Sponsor	Trials
Industry	12
Other	3

Export unavailable in trial.
Subscribe for complete access.